59 related articles for article (PubMed ID: 32016957)
1. Prevalence of cervical HPV and attitude towards cervical screening in IBD patients under immunomodulatory treatment: a multidisciplinary management experience.
Ricci C; Scaldaferri F; Colombo F; Armuzzi A; Lopetuso LR; Leone S; Gasbarrini A; Scambia G; De Vincenzo RP
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):564-570. PubMed ID: 32016957
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of abnormal Pap smear results in inflammatory bowel disease: a prospective study.
Brunner A; Kruis W; Schömig-Markiefka B; Morgenstern J; Engels M; Büttner R; Forner DM
J Cancer Res Clin Oncol; 2022 Nov; 148(11):3071-3079. PubMed ID: 34981194
[TBL] [Abstract][Full Text] [Related]
3. Human papilloma virus infection and cervical dysplasia.
Melinte-Popescu A; Costăchescu G
Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):853-7. PubMed ID: 23272541
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of human papillomavirus infection among women from quilombo communities in northeastern Brazil.
Nascimento MDDSB; Vidal FCB; Silva MACND; Batista JE; Lacerda Barbosa MDC; Muniz Filho WE; Bezerra GFB; Castro Viana GM; Branco RCC; Brito LMO
BMC Womens Health; 2018 Jan; 18(1):1. PubMed ID: 29291721
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015.
Balanda M; Quiero A; Vergara N; Espinoza G; Martín HS; Rojas G; Ramírez E
Med Microbiol Immunol; 2016 Dec; 205(6):585-594. PubMed ID: 27539577
[TBL] [Abstract][Full Text] [Related]
6. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
[TBL] [Abstract][Full Text] [Related]
7. [Multi-center cross-sectional study on type-specific human papillomavirus infection among Chinese women].
Zhao Y; Zhao F; Hu S; Chen W; Chen F; Cui J; Liu B; Zhang W; Zhang X; Pan Q; Qiao Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1351-6. PubMed ID: 26850387
[TBL] [Abstract][Full Text] [Related]
8. [Epidemiology of HPV infections and cervical cancer in Apulia: a survey study and current data analysis].
Martinelli D; Chironna M; Tafuri S; Neve A; Caputi G; Prato R; Germinario C; Quarto M
Ann Ig; 2007; 19(6):499-508. PubMed ID: 18376570
[TBL] [Abstract][Full Text] [Related]
9. Self-sampling coupled to the detection of HPV 16 and 18 E6 protein: A promising option for detection of cervical malignancies in remote areas.
Torres KL; Mariño JM; Pires Rocha DA; de Mello MB; de Melo Farah HH; Reis RDS; Alves VDCR; Gomes E; Martins TR; Soares AC; de Oliveira CM; Levi JE
PLoS One; 2018; 13(7):e0201262. PubMed ID: 30036381
[TBL] [Abstract][Full Text] [Related]
10. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology.
Ali MAM; Bedair RN; Abd El Atti RM
Cancer Cytopathol; 2019 Sep; 127(9):567-577. PubMed ID: 31390155
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
12. Correlation between integration of high-risk HPV genome into human DNA detected by molecular combing and the severity of cervical lesions: first results of the EXPL-HPV-002 study.
Bouchilloux S; Fer F; Lemée F; Barradeau S; Dvorak V; Kubickova S; Ventruba P; Tachezy R; Trnková M; Janda P; Abscheidt J; Annibal E; El Mhali D; Garcia F; Kech M; Pilger G; Bensimon A; Mahé F
Ceska Gynekol; 2019; 84(2):84-92. PubMed ID: 31238677
[TBL] [Abstract][Full Text] [Related]
13. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans.
Maver PJ; Poljak M
Clin Microbiol Infect; 2020 May; 26(5):579-583. PubMed ID: 31539637
[TBL] [Abstract][Full Text] [Related]
14. HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program.
Tabrizi SN; Brotherton JM; Stevens MP; Condon JR; McIntyre P; Smith D; Garland SM;
J Clin Virol; 2014 Jul; 60(3):250-6. PubMed ID: 24854516
[TBL] [Abstract][Full Text] [Related]
15. [Influence of Age in the Prevalence of High-Risk Human Papiloma Virus in Women with Pre-Neoplasic Cervical Lesions in Navarra, Spain].
Mercado Gutiérrez MR; Arean Cuns C; Gómez Dorronsoro ML; Paniello Alastruey I; Mallor Giménez F; Lozano Escario MD; Santamaría Martínez M
Rev Esp Salud Publica; 2017 Feb; 91():. PubMed ID: 28181989
[TBL] [Abstract][Full Text] [Related]
16. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of HPV-DNA in cervical smear samples by two different methods: MY09/11 consensus PCR and type-specific real-time PCR].
Sahiner F; Gümral R; Sener K; Yiğit N; Dede M; Yapar M; Kubar A
Mikrobiyol Bul; 2012 Oct; 46(4):624-36. PubMed ID: 23188576
[TBL] [Abstract][Full Text] [Related]
18. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
[TBL] [Abstract][Full Text] [Related]
20. Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program.
Machalek DA; Roberts JM; Garland SM; Thurloe J; Richards A; Chambers I; Sivertsen T; Farnsworth A
Med J Aust; 2019 Aug; 211(3):113-119. PubMed ID: 31168828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
